Cargando…
Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (R...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390193/ https://www.ncbi.nlm.nih.gov/pubmed/25853493 http://dx.doi.org/10.1371/journal.pone.0125176 |
_version_ | 1782365653625208832 |
---|---|
author | Guo, Kaifeng Lu, Junxi Huang, Yan Wu, Mian Zhang, Lei Yu, Haoyong Zhang, Mingliang Bao, Yuqian He, John Cijiang Chen, Haibing Jia, Weiping |
author_facet | Guo, Kaifeng Lu, Junxi Huang, Yan Wu, Mian Zhang, Lei Yu, Haoyong Zhang, Mingliang Bao, Yuqian He, John Cijiang Chen, Haibing Jia, Weiping |
author_sort | Guo, Kaifeng |
collection | PubMed |
description | The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1α-overexpressing plasmid (pcDNA3-PGC-1α) for 48 h. In the diabetic rats, decreased PGC-1α expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1α, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1α. These data suggest that PGC-1α may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN. |
format | Online Article Text |
id | pubmed-4390193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43901932015-04-21 Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling Guo, Kaifeng Lu, Junxi Huang, Yan Wu, Mian Zhang, Lei Yu, Haoyong Zhang, Mingliang Bao, Yuqian He, John Cijiang Chen, Haibing Jia, Weiping PLoS One Research Article The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1α-overexpressing plasmid (pcDNA3-PGC-1α) for 48 h. In the diabetic rats, decreased PGC-1α expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1α, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1α. These data suggest that PGC-1α may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN. Public Library of Science 2015-04-08 /pmc/articles/PMC4390193/ /pubmed/25853493 http://dx.doi.org/10.1371/journal.pone.0125176 Text en © 2015 Guo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Guo, Kaifeng Lu, Junxi Huang, Yan Wu, Mian Zhang, Lei Yu, Haoyong Zhang, Mingliang Bao, Yuqian He, John Cijiang Chen, Haibing Jia, Weiping Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling |
title | Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling |
title_full | Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling |
title_fullStr | Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling |
title_full_unstemmed | Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling |
title_short | Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling |
title_sort | protective role of pgc-1α in diabetic nephropathy is associated with the inhibition of ros through mitochondrial dynamic remodeling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390193/ https://www.ncbi.nlm.nih.gov/pubmed/25853493 http://dx.doi.org/10.1371/journal.pone.0125176 |
work_keys_str_mv | AT guokaifeng protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT lujunxi protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT huangyan protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT wumian protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT zhanglei protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT yuhaoyong protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT zhangmingliang protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT baoyuqian protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT hejohncijiang protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT chenhaibing protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling AT jiaweiping protectiveroleofpgc1aindiabeticnephropathyisassociatedwiththeinhibitionofrosthroughmitochondrialdynamicremodeling |